Q&A with Dr. Ashlee Brunaugh: Designing Inhaled Drugs to Overcome Antibiotic Resistance
Antibiotics are becoming less effective at treating infections as bacteria adapt over time and no longer respond to medicines. This problem of antimicrobial resistance is one of the top 10 global public health threats facing humanity, according to the World Health Organization.
Ashlee Brunaugh, PhD, PharmD, assistant professor of pharmaceutical sciences at the University of Michigan, aims to overcome antimicrobial resistance by developing novel inhaled therapeutics to treat bacterial lung infections. The PhRMA Foundation awarded Brunaugh a 2023 Faculty Starter Grant in Drug Delivery to support her work.
Watch this video to learn about Brunaugh and her research.
Subscribe to our Blog!
The PhRMA Foundation's blog brings you the latest developments in health care value assessment.